Sirdás sisdollui
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Giella
Buot deaivamat
Bajilčálus
Dahkki
Fáddá
Hildobáiki
ISBN/ISSN
Fáddágilkor
Viečča
Aiddostahtton
PASD1, a DLBCL-associated canc...
Čujuhandieđut
Deakstadieđáhus
Sádde šleađgaboasttain
Čálit
Doalvvo čujuhusa
Doalvun: RefWorks
Doalvun: EndNoteWeb
Doalvun: EndNote
Bissovaš liŋka
PASD1, a DLBCL-associated cancer testis antigen and candidate for lymphoma immunotherapy.
Bibliográfalaš dieđut
Váldodahkkit:
Cooper, C
,
Liggins, A
,
Ait-Tahar, K
,
Roncador, G
,
Banham, A
,
Pulford, K
Materiálatiipa:
Journal article
Giella:
English
Almmustuhtton:
2006
Oažžasuvvandieđut
Govvádus
Geahča maid
Bargiidšearbma
Govvádus
Čoahkkáigeassu:
Geahča maid
Cytotoxic T-Cell Response to the Cancer Testis Antigen PASD1 In Multiple Myeloma: PASD1 Peptides for a Generic Vaccine to Treat PASD1-Positive Haematological Malignancies.
Dahkki: Campbell, A, et al.
Almmustuhtton: (2010)
Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma.
Dahkki: Ait-Tahar, K, et al.
Almmustuhtton: (2009)
PASD1 is a potential multiple myeloma-associated antigen.
Dahkki: Sahota, S, et al.
Almmustuhtton: (2006)
DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.
Dahkki: Joseph-Pietras, D, et al.
Almmustuhtton: (2010)
Cytotoxic T-cell response to the PASD1 protein in patients with diffuse large B-cell lymphoma
Dahkki: Ait-Tahar, K, et al.
Almmustuhtton: (2009)